Merz Pharmaceuticals GmbH
61 clinical trials · Sponsor
◉ Watch Merz Pharmaceuticals GmbH
| Record | Firm | Date |
|---|---|---|
| A Study to Evaluate the Distribution of Botulinum Neurotoxin Type A Administered as Intradermal Injections, Comparing Different Doses, Concentrations, and Delivery Methods (NCT05585398) | Merz Pharmaceuticals GmbH | 2022-10-19 |
| A Study to Investigate the Efficacy and Safety of NT 201 (Botulinum Toxin) Compared With Placebo for the Treatment of Adult Participants With Essential Tremor in the Arm (NCT04766723) | Merz Pharmaceuticals GmbH | 2021-02-24 |
| Study to Compare the Efficacy and Safety of NT 201 (Botulinum Toxin) With Placebo for the Treatment of Lower Limb Spasticity Caused by Stroke or Traumatic Brain Injury (NCT03992404) | Merz Pharmaceuticals GmbH | 2019-09-16 |
| Local Study of Akatinol Memantine in VaD in Russia (NCT03986424) | Merz Pharmaceuticals GmbH | 2018-01-23 |
Track Merz Pharmaceuticals GmbH automatically
Every clearance here is in the API, with alerts when new ones post.